Driving clinical research forward with globally harmonized flow cytometry solutions
Flow cytometry is essential in clinical trials for targeted therapies, enabling precise analysis of immune responses, biomarkers and treatment effects. Collaborations with expert laboratories ensure customized assay development, validation and global harmonization. In this article, ICON introduces these key practices, including early communication, rigorous validation, quality control, and leveraging advanced spectral flow cytometry for efficient drug development and patient monitoring.
Driving clinical research forward with globally harmonised flow cytometry solutions
This feature is part of the Bioanalysis Zone Spotlight on flow cytometry in bioanalysis. For more expert opinions on this topic, visit our feature homepage.
This feature was produced in association with:
